Showing 261 - 280 results of 4,407 for search '"Pharmaceutical"', query time: 0.07s Refine Results
  1. 261
  2. 262
  3. 263

    Rapid Discrimination of Chlorpheniramine Maleate and Assessment of Its Surface Content Uniformity in a Pharmaceutical Formulation by NIR-CI Coupled with Statistical Measurement by Luwei Zhou, Zhisheng Wu, Xinyuan Shi, Manfei Xu, Xiaona Liu, Bing Xu, Yanjiang Qiao

    Published 2014-01-01
    “…This study demonstrated that near infrared chemical imaging (NIR-CI) was a rapid and nondestructive technique for discrimination of chlorpheniramine maleate (CPM) and assessment of its surface content uniformity (SCU) in a pharmaceutical formulation. The characteristic wavenumber method was used for discriminating CPM distribution on the tablet surface. …”
    Get full text
    Article
  4. 264
  5. 265
  6. 266

    RP-HPLC Analytical Method Development and Validation for Simultaneous Estimation of Three Drugs: Glimepiride, Pioglitazone, and Metformin and Its Pharmaceutical Dosage Forms by Gadapa Nirupa, Upendra M. Tripathi

    Published 2013-01-01
    “…The validated method was successfully applied to the commercially available pharmaceutical dosage form, yielding very good and reproducible result.…”
    Get full text
    Article
  7. 267
  8. 268
  9. 269

    Physicians’ attitudes towards disclosure of payments from pharmaceutical companies in a nationwide voluntary transparency database: a cross-sectional survey by Marlene Stoll, Lara Hubenschmid, Cora Koch, Klaus Lieb, Boris Egloff

    Published 2022-06-01
    “…Objectives To investigate German physicians’ attitudes towards and experiences with voluntary disclosure of payments by pharmaceutical companies in a public database and their impact on future decisions for or against disclosure.Design A national cross-sectional survey conducted in 2018 among physicians who voluntarily disclosed at least one payment in the German transparency regulation.Setting Retrospective paper-pencil questionnaire about attitudes towards and experiences with voluntary payment disclosures in the first (2015) and second (2016) years of the German transparency regulation.Participants German physicians who disclosed either in the first year only, the second year only, or in both years of the transparency regulation.Primary outcomes (1) The probability to disclose in 2016, predicted by physicians’ experience of reactions from others in 2015, descriptive norms and attitudes towards transparency; (2) Frequency and (3) Content of reactions from others in 2015 compared with 2016.Results Data of 234 respondents were analysed (n=42, 45 and 147 physicians who disclosed in 2015, 2016 or both years, respectively). …”
    Get full text
    Article
  10. 270

    Total phenolic content, flavonoid content and antioxidant potential of Petasites hybridus and related species from Croatia and considerations regarding their pharmaceutical significance by Friščić Maja, Vilić Katarina, Jurić Sandra, Pilepić Kroata Hazler, Maleš Željan

    Published 2024-12-01
    “…Extracts obtained from common butterbur (Petasites hybridus), standardized to petasins, are existing pharmaceutical options for the treatment and/or prevention of allergic rhinitis (leaves) and migraine (rhizomes). …”
    Get full text
    Article
  11. 271
  12. 272
  13. 273
  14. 274

    Determination of Atenolol and Trimetazidine in Pharmaceutical Tablets and Human Urine Using a High Performance Liquid Chromatography-Photo Diode Array Detection Method by Walaa El-Alfy, Omnia A. Ismaiel, Magda Y. El-Mammli, Abdalla Shalaby

    Published 2019-01-01
    “…Linearity was obtained over a concentration range of (1.0-100 μg/mL) for both analytes in standard solutions and the method was successfully applied for determination of target analytes in their pharmaceutical tablets. Excellent linearity was also obtained over concentration ranges of (0.25-25 μg/mL) and (0.5-25 μg/mL) in human urine for TMZ and ATN, respectively. …”
    Get full text
    Article
  15. 275
  16. 276

    Medical students’ exposure to and attitudes towards product promotion and incentives from the pharmaceutical industry in 2019: a national cross-sectional study in France by Maxime Esvan, Benjamin Bastian, Martin Molina, Adeline Boëffard

    Published 2022-07-01
    “…Objectives To measure medical students’ exposure to pharmaceutical product promotion and incentives nationwide, and to evaluate students’ attitudes towards the pharmaceutical industry, access to education on promotional strategies and knowledge of institutional policies about drug company-student relationships.Design Cross-sectional survey based on a 48-item anonymous questionnaire.Setting All 37 French medical schools, from March to April 2019.Participants French medical students in their 4th year of study and beyond, having studied exclusively in France.Main outcome measure Cumulative frequency of students’ exposure to pharmaceutical product promotion and incentives.Secondary outcome measures Exposure within the last 6 months, attitudes regarding interactions with the industry, access to education on pharmaceutical product promotion and incentives and knowledge of institutional policies.Results 6280 responses were analysed (10.4% out of a total of 60 550 eligible students). 5992 students (96.3% poststratification, 99% CI (96.1% to 96.5%)) had already been exposed to pharmaceutical product promotion and incentives and 4650 (78.1%, 99% CI (77.7% to 78.6%)) within the last 6 months. 5140 students (85.4%, 99% CI (84.8% to 85.8%)) had met a pharmaceutical representative. …”
    Get full text
    Article
  17. 277

    Validation of an RPHPTLC-Densitometric Method Using Silica Gel 60 RP18WF254 for Simultaneous Determination of Nicotinamide in Selected Pharmaceutical Formulations by Małgorzata Dołowy, Alina Pyka

    Published 2015-01-01
    “…Developed method is accurate and precise (CV<3%) and may be successfully applied for the quality control of pharmaceutical formulations containing nicotinamide in the presence of its derivatives, such as N,N-diethylnicotinamide, N-methylnicotinamide, and nicotinic acid.…”
    Get full text
    Article
  18. 278

    Identifying and ranking the circular supply chain implementation challenges using pythagorean fuzzy SWARA approach (case of study: pharmaceutical industry of Guilan province) by Samaneh Rash, Mostafa Ebrahimpour Azbari, Mohammad Rahim Ramazanian

    Published 2023-11-01
    “…We used the proposed method in the pharmaceutical industry of the Guilan province.Findings: In the final results of the research, Strategic Challenges (SCs) and operational and environmental challenges are prioritized.Originality/Value: This research serves as a step for industry practitioners to efficiently and effectively adopt a CSC.…”
    Get full text
    Article
  19. 279

    Comparative efficacy and safety of 20 intravenous pharmaceutical intervention for prevention of etomidate-induced myoclonus: a systematic review and Bayesian network meta-analysis by Lu Chen, Lu Chen, Pengxiang Zhou, Pengxiang Zhou, Zhengqian Li, Ziyang Wu, Suodi Zhai, Suodi Zhai

    Published 2025-01-01
    “…We included randomized controlled trials (RCTs) comparing intravenous pharmaceutical interventions to prevent EIM with placebo, no intervention, or another pharmaceutical intervention.ResultsForty-eight RCTs involving 4,768 participants randomly assigned to 20 intravenous pharmaceutical interventions and normal saline were included. …”
    Get full text
    Article
  20. 280